Vitrolife AB (publ) (VTRLY)

OTCMKTS · Delayed Price · Currency is USD
15.87
+0.97 (6.51%)
Aug 28, 2025, 2:39 PM EDT
6.51%
Market Cap1.90B
Revenue (ttm)372.37M
Net Income (ttm)47.85M
Shares Outn/a
EPS (ttm)0.35
PE Ratio39.72
Forward PE30.88
Dividend0.07 (0.46%)
Ex-Dividend DateMay 2, 2025
Volume1
Average Volume2
Open15.87
Previous Close14.90
Day's Range15.87 - 15.87
52-Week Range14.62 - 25.00
Beta1.78
RSI28.71
Earnings DateOct 23, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden. [Read more]

Sector Healthcare
Founded 1989
Employees 1,169
Stock Exchange OTCMKTS
Ticker Symbol VTRLY
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

Vitrolife AB (publ) reports Q2 results

6 weeks ago - Seeking Alpha

Vitrolife CFO Patrik Tolf to step down

9 months ago - Seeking Alpha

Vitrolife AB (publ) reports Q3 results

11 months ago - Seeking Alpha